TAVI Market by Procedure (Transfemoral Implantation, Transapical Implantation, and Transaortic Implantation), and by End-user (Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers)- Global Opportunity Analysis and Industry Forecast 2022-2030

TAVI Market

Industry:  Life Sciences & Healthcare | Publish Date: Mar 2020 | No of Pages:  215 | No. Tables:  118 | No. Figures:  88

Market Definition:

The TAVI Market was valued at USD 4.89 billion in 2021 and is predicted to reach USD 16.32 billion by 2030, registeringa CAGR of 14.6% from 2022 to 2030.

Transcatheter aortic valve implantation (TAVI) also known as transcatheter aortic valve replacement (TAVR) is an open-heart surgery that is performed to treat aortic stenosis. An aorta is a large artery that carries blood from the heart to the rest of the body. TAVI isa minimally invasive method that is designed to replace a diseased aortic valve with an artificial valve through blood vessels, without removing the old, damaged valve. This method is used for the renewal of dysfunctional and damaged heart valves, especially for high-risk category patients that are unfit to undergo an operation or surgical valve replacement (SAVR) procedure.

Market Dynamics and Trends

The demand for TAVI is increasing due to the rise in the prevalence of aortic stenosis coupled with developments in healthcare infrastructure for TAVR across various healthcare institutes including Minneapolis Heart Institute and Asian Heart Institute. Also, factors such as advancements in transcatheter aortic valves that include improved pre-procedural assessmentwith dedicated protocols of computed tomography (CT) image acquisition and reconstructionas well asa rise in demand for various TAVI procedures to treat cardiovascular issues are expected to drive the TAVI market growth for the market.

Moreover, TAVI has become a well-known standard of care for patients unable to undergo an operation.The improved awareness among patients & physicians about the benefits of transcatheter aortic is anticipated to drive the growth of the TAVI market during the forecast time frame. For instance, in September 2020, The Heart Valve Centre, a unit of HeartTeam India presented the TAVR World Tour to educate the masses about modern cardiac treatments. It is the first cardiovascular health awareness campaign comprising 20 cardiac specialist teams from 20 different cities across the world live on one global platform (JioMeet).

The lack of skilled healthcare professionals and the high cost of treatment are factors that are expected to restrain the market growth of TAVI during the forecast period. On the other hand, a lower risk of infection as a result of technological advancements such as new-generation TAVI devices is expected to create new opportunities for market growth in the future.

 

Market Segmentations and Scope of the Study

The global TAVI market is segmented based on procedure, end-user, and geography. Based on procedure, the market is divided into transfemoral implantation, transapical implantation, and transaortic implantation. Based on end-user, the market is classified into hospitals, cardiac catheterization laboratories, and ambulatory surgical centers. The geographic breakdown and analysis of each of the preceding divisions involve regions comprising North America, Europe, Asia-Pacific, and RoW.

 

Geographical Analysis

North America heldthe lion’s share of the global TAVI market in 2021 and is expected to continue dominating the market during the forecast period. This is attributed to factors such as the presence of developed healthcare infrastructure along with high R&D expenditure for the development of these devices. Also, the rise in the prevalence of coronary artery diseases, hypertension, or heart failurethat needs surgical aortic treatment is supplementing the market growth.

Moreover, the demand for TAVI is increasing due to the surging prevalence in the U.S., which consists of a large geriatric population, that is most vulnerable to valvularaortic stenosis. For instance, in 2020, according to the Americal College of Cardiology, since the approval of the first transcatheter aortic valve replacement (TAVR) device in 2011, more than 276,000 patients have undergone a TAVR procedure in the U.S.

Asia-Pacific is expected to exhibita steady rise in the global TAVI market during the forecast period, due to factors such as increasing incidences of cardiovascular disorders, and rising accessibility to healthcare facilities in this region. Also, growing medical tourismin countries such as Japan, Thailand, and Singapore, including procedures of TAVI in the regionis expected to fuel the market in this region.

Moreover, the presence of key companies such as Meril Life Sciences Pvt. Ltd and Venus Medtech, Inc., that adopt various strategies to expand their business in this region is propelling the growth of the TAVI market. For instance, in July 2020, Venus Medtech announced a collaboration with Pi-Cardia Ltd.to introduce Pi-Cardia's Leaflex™ technology to China. This was aimed at enabling a lower-cost non-implant-based solution for patients with calcified aortic valves.

 

Competitive Landscape

The TAVI market comprises key players such as Abbott, JC Medical Inc., Meril Life Sciences Pvt. Ltd., HLT, Inc. (Bracco), Boston Scientific Corporation, JenaValve Technology Inc., Edwards Lifesciences Corporation, Medtronic, Venus Medtech (Hangzhou) Inc, and NVT AG (Blue Sail Medical) among others. These playersare actively indulging in R&D initiatives, product & technology innovations, and industrial collaborations to enhance their products and increase their sales growth and geographical reach.

For instance, in August 2021, Medtronic plc announced the approval of the U.S. Food and Drug Administration (FDA) for its newest-generation, self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut™ FX TAVR system. It is designed specially to enhance easeofuse and provide greater precision and control throughout the procedure. Additionally, in September 2021, Abbott announced the U.S FDA approval of the company's Portico with FlexNav transcatheter aortic valve replacement (TAVR) system in order to treat people suffering from severe aortic stenosis, symptomatic that are at extreme risk for open-heart surgery through minimally invasive therapies.

KEY BENEFITS

  • The TAVI market report provides aquantitative analysis of the current market and estimations through 2022-2030 that assists in identifying the prevailing market opportunities to capitalize on.

  • The study comprises a deep dive analysis of TAVI market trends, including the current and future trends for depicting the prevalent investment pockets in the market.

  • The information related to key drivers, restraints, and opportunities and their impact on the TAVI market is provided in the report.

  • The competitive analysis of the market players along with their market share in the global TAVI market.

  • The SWOT analysis and Porter’s Five Forces model areelaborated in the study.

  • Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.

KEY MARKET SEGMENTS

By Procedure

  • Transfemoral Implantation

  • Transapical Implantation

  • Transaortic Implantation

By End User

  • Hospitals

  • Cardiac Catheterization Laboratories

  • Ambulatory Surgical Centers

By Geography

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Rest of Europe

  • Asia-Pacific

    • China

    • India

    • Japan

    • Australia

    • Rest of Asia-Pacific

  • RoW

    • UAE

    • Saudi Arabia

    • South Africa

    • Brazil

    • Rest of the World

1.... INTRODUCTION

1.1.           REPORT DESCRIPTION

1.2.           Research Methodology

1.2.1             Secondary Research

1.2.2             Data Analysis Framework

1.2.3             Market size estimation

1.2.4             Forecasting

1.2.5             Primary Research and Data Validation

2.... MARKET SNAPSHOT, 2019-2030 Million USD

2.1.           MARKET SNAPSHOT

3.... PORTER’S FIVE FORCE MODEL ANALYSIS

4.... MARKET DYNAMICS

4.1.           GROWTH DRIVERS

4.1.1             DRIVER 1

4.1.2             DRIVER 2

4.1.3             DRIVER 3

4.1.4             DRIVER 4

4.2.           CHALLENGES

4.2.1             CHALLENGE 1

4.2.2             CHALLENGE 2

4.3.           OPPORTUNITIES

4.3.1             OPPORTUNITY 1

4.3.2             OPPORTUNITY 2

5.... Global  Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

5.1.           Overview

5.2.           Transfemoral Implantation

5.2.1             Transfemoral Implantation Market, By Region

5.2.1.1        North America Transfemoral Implantation Market, By Country

5.2.1.2        Europe Transfemoral Implantation Market, By Country

5.2.1.3        Asia-Pacific Transfemoral Implantation Market, By Country

5.2.1.4        Rest of World Transfemoral Implantation Market, By Country

5.3.           Transapical Implantation

5.3.1             Transapical Implantation Market, By Region

5.3.1.1        North America Transapical Implantation Market, By Country

5.3.1.2        Europe Transapical Implantation Market, By Country

5.3.1.3        Asia-Pacific Transapical Implantation Market, By Country

5.3.1.4        Rest of World Transapical Implantation Market, By Country

5.4.           Transaortic Implantation

5.4.1             Transaortic Implantation Market, By Region

5.4.1.1        North America Transaortic Implantation Market, By Country

5.4.1.2        Europe Transaortic Implantation Market, By Country

5.4.1.3        Asia-Pacific Transaortic Implantation Market, By Country

5.4.1.4        Rest of World Transaortic Implantation Market, By Country

6.... Global  Transcatheter Aortic Valve Implantation (TAVI) Market, By Region

6.1.           Overview

6.2.           North America

6.2.1             North America Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.2.2             North America Transcatheter Aortic Valve Implantation (TAVI), Market By Country

6.2.2.1        U.S.

6.2.2.1.1        U.S. Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.2.2.2        Canada

6.2.2.2.1        Canada Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.2.2.3        Mexico

6.2.2.3.1        Mexico Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.3.           Europe

6.3.1             Europe Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.3.2             Europe Transcatheter Aortic Valve Implantation (TAVI), Market By Country

6.3.2.1        UK

6.3.2.1.1        UK Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.3.2.2        France

6.3.2.2.1        France Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.3.2.3        Germany

6.3.2.3.1        Germany Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.3.2.4        Italy

6.3.2.4.1        Italy Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.3.2.5        Switzerland

6.3.2.5.1        Switzerland Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.3.2.6        Rest of Europe

6.3.2.6.1        Rest of Europe Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.4.           Asia-Pacific

6.4.1             Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.4.2             Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI), Market By Country

6.4.2.1        China

6.4.2.1.1        China Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.4.2.2        India

6.4.2.2.1        India Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.4.2.3        Japan

6.4.2.3.1        Japan Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.4.2.4        Rest of Asia-Pacific

6.4.2.4.1        Rest of Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.5.           Rest of World

6.5.1             Rest of World Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.5.2             Rest of World Transcatheter Aortic Valve Implantation (TAVI), Market By Country

6.5.2.1        Brazil

6.5.2.1.1        Brazil Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.5.2.2        South Africa

6.5.2.2.1        South Africa Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.5.2.3        Israel

6.5.2.3.1        Israel Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.5.2.4        Saudi Arabia

6.5.2.4.1        Saudi Arabia Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

6.5.2.5        Remaining Countries

6.5.2.5.1        Remaining Countries Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure

7.... COMPANY PROFILES

7.1.           ABBOTT LABORATORIES

7.1.1             COMPANY OVERVIEW

7.1.2             COMPANY SNAPSHOT

7.1.3             OPERATING BUSINESS SEGMENTS

7.1.4             PRODUCT PORTFOLIO

7.1.5             BUSINESS PERFORMANCE

7.1.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.2.           BOSTON SCIENTIFIC CORPORATION

7.2.1             COMPANY OVERVIEW

7.2.2             COMPANY SNAPSHOT

7.2.3             OPERATING BUSINESS SEGMENTS

7.2.4             PRODUCT PORTFOLIO

7.2.5             BUSINESS PERFORMANCE

7.2.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.3.           BRACCO S.P.A.

7.3.1             COMPANY OVERVIEW

7.3.2             COMPANY SNAPSHOT

7.3.3             OPERATING BUSINESS SEGMENTS

7.3.4             PRODUCT PORTFOLIO

7.3.5             BUSINESS PERFORMANCE

7.3.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.4.           EDWARDS LIFESCIENCES CORPORATION

7.4.1             COMPANY OVERVIEW

7.4.2             COMPANY SNAPSHOT

7.4.3             OPERATING BUSINESS SEGMENTS

7.4.4             PRODUCT PORTFOLIO

7.4.5             BUSINESS PERFORMANCE

7.4.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.5.           JENAVALVE TECHNOLOGY, INC.

7.5.1             COMPANY OVERVIEW

7.5.2             COMPANY SNAPSHOT

7.5.3             OPERATING BUSINESS SEGMENTS

7.5.4             PRODUCT PORTFOLIO

7.5.5             BUSINESS PERFORMANCE

7.5.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.6.           JC MEDICAL, INC.

7.6.1             COMPANY OVERVIEW

7.6.2             COMPANY SNAPSHOT

7.6.3             OPERATING BUSINESS SEGMENTS

7.6.4             PRODUCT PORTFOLIO

7.6.5             BUSINESS PERFORMANCE

7.6.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.7.           MEDTRONIC PLC.

7.7.1             COMPANY OVERVIEW

7.7.2             COMPANY SNAPSHOT

7.7.3             OPERATING BUSINESS SEGMENTS

7.7.4             PRODUCT PORTFOLIO

7.7.5             BUSINESS PERFORMANCE

7.7.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.8.           MERIL LIFE SCIENCES PVT. LTD.

7.8.1             COMPANY OVERVIEW

7.8.2             COMPANY SNAPSHOT

7.8.3             OPERATING BUSINESS SEGMENTS

7.8.4             PRODUCT PORTFOLIO

7.8.5             BUSINESS PERFORMANCE

7.8.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.9.           NVT AG

7.9.1             COMPANY OVERVIEW

7.9.2             COMPANY SNAPSHOT

7.9.3             OPERATING BUSINESS SEGMENTS

7.9.4             PRODUCT PORTFOLIO

7.9.5             BUSINESS PERFORMANCE

7.9.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.10.         VENUS MEDTECH, INC.

7.10.1           COMPANY OVERVIEW

7.10.2           COMPANY SNAPSHOT

7.10.3           OPERATING BUSINESS SEGMENTS

7.10.4           PRODUCT PORTFOLIO

7.10.5           BUSINESS PERFORMANCE

7.10.6           KEY STRATEGIC MOVES AND DEVELOPMENT

LIST OF TABLES

TABLE 1.         Global  Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 2.         Global  Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 3.         Transfemoral Implantation Market Value, By Region, 2019-2030, Million USD

TABLE 4.         Transfemoral Implantation Market Volume, By Region, 2019-2030, Units

TABLE 5.         North America Transfemoral Implantation Market Value, By Country, 2019-2030, Million USD

TABLE 6.         North America Transfemoral Implantation Market Volume, By Country, 2019-2030, Units

TABLE 7.         Europe Transfemoral Implantation Market Value, By Country, 2019-2030, Million USD

TABLE 8.         Europe Transfemoral Implantation Market Volume, By Country, 2019-2030, Units

TABLE 9.         Asia-Pacific Transfemoral Implantation Market Value, By Country, 2019-2030, Million USD

TABLE 10.       Asia-Pacific Transfemoral Implantation Market Volume, By Country, 2019-2030, Units

TABLE 11.       Rest of World Transfemoral Implantation Market Value, By Country, 2019-2030, Million USD

TABLE 12.       Rest of World Transfemoral Implantation Market Volume, By Country, 2019-2030, Units

TABLE 13.       Transapical Implantation Market Value, By Region, 2019-2030, Million USD

TABLE 14.       Transapical Implantation Market Volume, By Region, 2019-2030, Units

TABLE 15.       North America Transapical Implantation Market Value, By Country, 2019-2030, Million USD

TABLE 16.       North America Transapical Implantation Market Volume, By Country, 2019-2030, Units

TABLE 17.       Europe Transapical Implantation Market Value, By Country, 2019-2030, Million USD

TABLE 18.       Europe Transapical Implantation Market Volume, By Country, 2019-2030, Units

TABLE 19.       Asia-Pacific Transapical Implantation Market Value, By Country, 2019-2030, Million USD

TABLE 20.       Asia-Pacific Transapical Implantation Market Volume, By Country, 2019-2030, Units

TABLE 21.       Rest of World Transapical Implantation Market Value, By Country, 2019-2030, Million USD

TABLE 22.       Rest of World Transapical Implantation Market Volume, By Country, 2019-2030, Units

TABLE 23.       Transaortic Implantation Market Value, By Region, 2019-2030, Million USD

TABLE 24.       Transaortic Implantation Market Volume, By Region, 2019-2030, Units

TABLE 25.       North America Transaortic Implantation Market Value, By Country, 2019-2030, Million USD

TABLE 26.       North America Transaortic Implantation Market Volume, By Country, 2019-2030, Units

TABLE 27.       Europe Transaortic Implantation Market Value, By Country, 2019-2030, Million USD

TABLE 28.       Europe Transaortic Implantation Market Volume, By Country, 2019-2030, Units

TABLE 29.       Asia-Pacific Transaortic Implantation Market Value, By Country, 2019-2030, Million USD

TABLE 30.       Asia-Pacific Transaortic Implantation Market Volume, By Country, 2019-2030, Units

TABLE 31.       Rest of World Transaortic Implantation Market Value, By Country, 2019-2030, Million USD

TABLE 32.       Rest of World Transaortic Implantation Market Volume, By Country, 2019-2030, Units

TABLE 33.       Global  Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Region, 2019-2030, Million USD

TABLE 34.       Global  Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Region, 2019-2030, Units

TABLE 35.       North America Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 36.       North America Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 37.       U.S. Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 38.       U.S. Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 39.       Canada Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 40.       Canada Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 41.       Mexico Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 42.       Mexico Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 43.       Europe Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 44.       Europe Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 45.       UK Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 46.       UK Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 47.       France Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 48.       France Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 49.       Germany Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 50.       Germany Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 51.       Italy Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 52.       Italy Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 53.       Switzerland Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 54.       Switzerland Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 55.       Rest of Europe Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 56.       Rest of Europe Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 57.       Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 58.       Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 59.       China Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 60.       China Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 61.       India Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 62.       India Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 63.       Japan Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 64.       Japan Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 65.       Rest of Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 66.       Rest of Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 67.       Rest of World Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 68.       Rest of World Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 69.       Brazil Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 70.       Brazil Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 71.       South Africa Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 72.       South Africa Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 73.       Israel Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 74.       Israel Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 75.       Saudi Arabia Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 76.       Saudi Arabia Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 77.       Remaining Countries Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

TABLE 78.       Remaining Countries Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

TABLE 79.       ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 80.       ABBOTT LABORATORIES: OPERATING SEGMENTS

TABLE 81.       ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 82.       ABBOTT LABORATORIES: KEY STRATERGY

TABLE 83.       BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

TABLE 84.       BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS

TABLE 85.       BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO

TABLE 86.       BOSTON SCIENTIFIC CORPORATION: KEY STRATERGY

TABLE 87.       BRACCO S.P.A.: COMPANY SNAPSHOT

TABLE 88.       BRACCO S.P.A.: OPERATING SEGMENTS

TABLE 89.       BRACCO S.P.A.: PRODUCT PORTFOLIO

TABLE 90.       BRACCO S.P.A.: KEY STRATERGY

TABLE 91.       EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT

TABLE 92.       EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS

TABLE 93.       EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO

TABLE 94.       EDWARDS LIFESCIENCES CORPORATION: KEY STRATERGY

TABLE 95.       JENAVALVE TECHNOLOGY, INC.: COMPANY SNAPSHOT

TABLE 96.       JENAVALVE TECHNOLOGY, INC.: OPERATING SEGMENTS

TABLE 97.       JENAVALVE TECHNOLOGY, INC.: PRODUCT PORTFOLIO

TABLE 98.       JENAVALVE TECHNOLOGY, INC.: KEY STRATERGY

TABLE 99.       JC MEDICAL, INC.: COMPANY SNAPSHOT

TABLE 100.    JC MEDICAL, INC.: OPERATING SEGMENTS

TABLE 101.    JC MEDICAL, INC.: PRODUCT PORTFOLIO

TABLE 102.    JC MEDICAL, INC.: KEY STRATERGY

TABLE 103.    MEDTRONIC PLC.: COMPANY SNAPSHOT

TABLE 104.    MEDTRONIC PLC.: OPERATING SEGMENTS

TABLE 105.    MEDTRONIC PLC.: PRODUCT PORTFOLIO

TABLE 106.    MEDTRONIC PLC.: KEY STRATERGY

TABLE 107.    MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT

TABLE 108.    MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS

TABLE 109.    MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO

TABLE 110.    MERIL LIFE SCIENCES PVT. LTD.: KEY STRATERGY

TABLE 111.    NVT AG: COMPANY SNAPSHOT

TABLE 112.    NVT AG: OPERATING SEGMENTS

TABLE 113.    NVT AG: PRODUCT PORTFOLIO

TABLE 114.    NVT AG: KEY STRATERGY

TABLE 115.    VENUS MEDTECH, INC.: COMPANY SNAPSHOT

TABLE 116.    VENUS MEDTECH, INC.: OPERATING SEGMENTS

TABLE 117.    VENUS MEDTECH, INC.: PRODUCT PORTFOLIO

TABLE 118.    VENUS MEDTECH, INC.: KEY STRATERGY

 

 

LIST OF FIGURES

FIGURE 1.       Global  Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 2.       Global  Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 3.       Transfemoral Implantation Market Value, By Region, 2019-2030, Million USD

FIGURE 4.       Transfemoral Implantation Market Volume, By Region, 2019-2030, Units

FIGURE 5.       North America Transfemoral Implantation Market Value, By Country, 2019-2030, Million USD

FIGURE 6.       North America Transfemoral Implantation Market Volume, By Country, 2019-2030, Units

FIGURE 7.       Europe Transfemoral Implantation Market Value, By Country, 2019-2030, Million USD

FIGURE 8.       Europe Transfemoral Implantation Market Volume, By Country, 2019-2030, Units

FIGURE 9.       Asia-Pacific Transfemoral Implantation Market Value, By Country, 2019-2030, Million USD

FIGURE 10.     Asia-Pacific Transfemoral Implantation Market Volume, By Country, 2019-2030, Units

FIGURE 11.     Rest of World Transfemoral Implantation Market Value, By Country, 2019-2030, Million USD

FIGURE 12.     Rest of World Transfemoral Implantation Market Volume, By Country, 2019-2030, Units

FIGURE 13.     Transapical Implantation Market Value, By Region, 2019-2030, Million USD

FIGURE 14.     Transapical Implantation Market Volume, By Region, 2019-2030, Units

FIGURE 15.     North America Transapical Implantation Market Value, By Country, 2019-2030, Million USD

FIGURE 16.     North America Transapical Implantation Market Volume, By Country, 2019-2030, Units

FIGURE 17.     Europe Transapical Implantation Market Value, By Country, 2019-2030, Million USD

FIGURE 18.     Europe Transapical Implantation Market Volume, By Country, 2019-2030, Units

FIGURE 19.     Asia-Pacific Transapical Implantation Market Value, By Country, 2019-2030, Million USD

FIGURE 20.     Asia-Pacific Transapical Implantation Market Volume, By Country, 2019-2030, Units

FIGURE 21.     Rest of World Transapical Implantation Market Value, By Country, 2019-2030, Million USD

FIGURE 22.     Rest of World Transapical Implantation Market Volume, By Country, 2019-2030, Units

FIGURE 23.     Transaortic Implantation Market Value, By Region, 2019-2030, Million USD

FIGURE 24.     Transaortic Implantation Market Volume, By Region, 2019-2030, Units

FIGURE 25.     North America Transaortic Implantation Market Value, By Country, 2019-2030, Million USD

FIGURE 26.     North America Transaortic Implantation Market Volume, By Country, 2019-2030, Units

FIGURE 27.     Europe Transaortic Implantation Market Value, By Country, 2019-2030, Million USD

FIGURE 28.     Europe Transaortic Implantation Market Volume, By Country, 2019-2030, Units

FIGURE 29.     Asia-Pacific Transaortic Implantation Market Value, By Country, 2019-2030, Million USD

FIGURE 30.     Asia-Pacific Transaortic Implantation Market Volume, By Country, 2019-2030, Units

FIGURE 31.     Rest of World Transaortic Implantation Market Value, By Country, 2019-2030, Million USD

FIGURE 32.     Rest of World Transaortic Implantation Market Volume, By Country, 2019-2030, Units

FIGURE 33.     Global  Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Region, 2019-2030, Million USD

FIGURE 34.     Global  Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Region, 2019-2030, Units

FIGURE 35.     North America Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 36.     North America Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 37.     U.S. Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 38.     U.S. Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 39.     Canada Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 40.     Canada Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 41.     Mexico Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 42.     Mexico Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 43.     Europe Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 44.     Europe Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 45.     UK Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 46.     UK Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 47.     France Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 48.     France Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 49.     Germany Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 50.     Germany Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 51.     Italy Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 52.     Italy Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 53.     Switzerland Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 54.     Switzerland Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 55.     Rest of Europe Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 56.     Rest of Europe Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 57.     Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 58.     Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 59.     China Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 60.     China Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 61.     India Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 62.     India Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 63.     Japan Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 64.     Japan Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 65.     Rest of Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 66.     Rest of Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 67.     Rest of World Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 68.     Rest of World Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 69.     Brazil Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 70.     Brazil Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 71.     South Africa Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 72.     South Africa Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 73.     Israel Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 74.     Israel Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 75.     Saudi Arabia Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 76.     Saudi Arabia Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 77.     Remaining Countries Transcatheter Aortic Valve Implantation (TAVI) Market Value, By Procedure, 2019-2030, Million USD

FIGURE 78.     Remaining Countries Transcatheter Aortic Valve Implantation (TAVI) Market Volume, By Procedure, 2019-2030, Units

FIGURE 79.     ABBOTT LABORATORIES: NET SALES,2017-2019

FIGURE 80.     BOSTON SCIENTIFIC CORPORATION: NET SALES,2017-2019

FIGURE 81.     BRACCO S.P.A.: NET SALES,2017-2019

FIGURE 82.     EDWARDS LIFESCIENCES CORPORATION: NET SALES,2017-2019

FIGURE 83.     JENAVALVE TECHNOLOGY, INC.: NET SALES,2017-2019

FIGURE 84.     JC MEDICAL, INC.: NET SALES,2017-2019

FIGURE 85.     MEDTRONIC PLC.: NET SALES,2017-2019

FIGURE 86.     MERIL LIFE SCIENCES PVT. LTD.: NET SALES,2017-2019

FIGURE 87.     NVT AG: NET SALES,2017-2019

FIGURE 88.     VENUS MEDTECH, INC.: NET SALES,2017-2019

KEY PLAYERS

  • Abbott 

  • JC Medical Inc.

  • Meril Life Sciences Pvt. Ltd.

  • HLT, Inc.(Bracco)

  • Boston Scientific Corporation 

  • JenaValve Technology, Inc.

  • Edwards Lifesciences Corporation.

  • Medtronic

  • Venus Medtech (Hangzhou) Inc.

  • NVT AG (Blue Sail Medical)